Celltrion
068270.KS
#774
Rank
C$35.87 B
Marketcap
$173.22
Share price
1.34%
Change (1 day)
-3.84%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Cash on Hand

Cash on Hand as of March 2024 : C$0.95 Billion

According to Celltrion 's latest financial reports the company has C$0.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celltrion - Cash on Hand chart (from 2007 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$0.63 B-51.04%
2021-12-31C$1.30 B59.42%
2020-12-31C$0.81 B15.58%
2019-12-31C$0.70 B9.19%
2018-12-31C$0.64 B-1.3%
2017-12-31C$0.65 B115.27%
2016-12-31C$0.30 B66.1%
2015-12-31C$0.18 B46.57%
2014-12-31C$0.12 B9.91%
2013-12-31C$0.11 B15.58%
2012-12-31C$98.82 M92.09%
2011-12-31C$51.44 M-52.83%
2010-12-31C$0.10 B442.96%
2009-12-31C$20.08 M389.54%
2008-12-31C$4.1 M-9.73%
2007-12-31C$4.54 M